Medications
Study finds no elevated risk of thyroid cancer among GLP1-RA users
A study has found no evidence that glucagon-like peptide 1 receptor agonist (GLP1-RA) use is associated with an increased risk of thyroid cancer.
Jan 13, 2025
0
0
Diabetes
Medications
Oral glucose-lowering agents are potential alternatives to insulin for gestational diabetes
With respect to the proportion of infants born large for gestational age, treatment of gestational diabetes with metformin and glyburide, if needed, does not meet the criteria for noninferiority versus insulin, according ...
Jan 9, 2025
0
0
Diabetes
How a protein affects the ability to secrete insulin in type 2 diabetes
In type 2 diabetes, the body's ability to release insulin is impaired, which leads to high blood glucose levels. Research led by Lund University shows how the levels of a particular protein are elevated in the pancreas of ...
Jan 8, 2025
0
20
Medical research
How specific brain regions drive chemotherapy-induced pain response
Chronic physical pain can be debilitating, but feelings of stress, fear, and hunger can sometimes suppress painful sensations. Diverse neurons across different brain regions play a role in carefully orchestrating the pain ...
Jan 8, 2025
0
4
Psychology & Psychiatry
Study sheds light on depression in community-dwelling older adults
Marked variation in the prevalence of depression was found in a multisite sample of community-dwelling older adults in the United States, reports a study by Columbia University Mailman School of Public Health. Until now, ...
Jan 8, 2025
0
0
Medications
Incident gabapentin use not linked to increase in falls vs. duloxetine
Incident use of gabapentin is not associated with an increase in fall-related hospital visits compared with duloxetine use, according to a study published online Jan. 7 in the Annals of Internal Medicine.
Jan 7, 2025
0
0
Medications
GLP-1 RAs efficacious for weight loss in overweight, obesity without diabetes
For adults with overweight or obesity without diabetes, glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are efficacious for weight loss, according to a review published online Jan. 7 in the Annals of Internal Medicine.
Jan 7, 2025
0
0
Diabetes
AI uses simple glucose monitor data to predict and identify subtypes of type 2 diabetes
Diabetes has long been lumped into two categories—type 1, which often appears in childhood, or type 2, which is associated with obesity and typically develops later in life. But scientists have learned that not all patients ...
Jan 7, 2025
0
100
Cardiology
Global study links millions of diabetes and heart disease cases to sugary drinks
A new study from researchers at the Gerald J. and Dorothy R. Friedman School of Nutrition Science and Policy at Tufts University, published in Nature Medicine, estimates that 2.2 million new cases of type 2 diabetes and 1.2 ...
Jan 6, 2025
0
134
Gerontology & Geriatrics
Age matters: Kidney disorder indicator gains precision
Annual health checkups regularly include urine tests that serve several purposes, including checking for symptoms of kidney disease. The presence of albumin in the urine is one indicator, as is glomerular filtration rate ...
Jan 6, 2025
0
2
